RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 47 filers reported holding RAIN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $110,000 | – | 22,635 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,560,652 | $8,677,000 | 2.31% |
| Cormorant Asset Management, LP | 2,326,660 | $12,936,000 | 0.98% |
| BVF INC/IL | 3,526,729 | $19,609,000 | 0.95% |
| Perceptive Advisors | 2,483,619 | $13,809,000 | 0.43% |
| Boxer Capital, LLC | 1,175,000 | $6,533,000 | 0.41% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 333,251 | $1,853,000,000 | 0.03% |
| Laurion Capital Management LP | 313,200 | $1,741,000 | 0.03% |
| Lumina Fund Management LLC | 6,000 | $33,000 | 0.01% |
| Ergoteles LLC | 70,700 | $393,000 | 0.01% |
| Woodline Partners LP | 119,700 | $666,000 | 0.01% |